-transparent.png){kind=logo}
We investigated the effect of levodopa on mood and anxiety in eight Parkinson's disease patients with motor fluctuations. Each patient received 0.0-, 0.5-, and 1.0-mg/kg/hr levodopa infusions in randomly assigned order under double-blind conditions on consecutive days. Mood elevation and anxiety reduction based on half-hourly patient rating and a corresponding increase in tapping speed occurred with active drug infusion but not placebo infusion. The effects were dose related. The higher-dose infusion rate produced more rapid onset, greater magnitude, and longer duration of response. We conclude that mood and anxiety fluctuations related to levodopa dosing are robust pharmacologic, and not placebo, effects.
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
December 1970,
Neurology,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
December 1970,
Neurology,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
October 2003,
Movement disorders : official journal of the Movement Disorder Society,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
January 2007,
Movement disorders : official journal of the Movement Disorder Society,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
February 1986,
Neurology,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
August 2003,
Journal of neurology, neurosurgery, and psychiatry,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
January 1986,
Neurologia (Barcelona, Spain),
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
January 2000,
Clinical neuropharmacology,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
January 2007,
Movement disorders : official journal of the Movement Disorder Society,
R A Maricle, and
J G Nutt, and
R J Valentine, and
J H Carter
November 2010,
Journal of neural transmission (Vienna, Austria : 1996),
